Survival analysis: The importance of censored observations

Melanoma Research

Volumn 6, Issue 5, 1996, Pages 379-385

  Watt, D C ^a   Aitchison, T C ^a   MacKie, R M ^a   Sirel, J M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

censored observations; Kaplan Meier; prediction; survival analysis

Indexed keywords

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; SURVIVAL;

BIAS (EPIDEMIOLOGY); FEMALE; HUMANS; MALE; MELANOMA; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 0029862805     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199610000-00005     Document Type: Article

References (17)

1. Clark WH, Elder DE, Guerry D, et al. Model predicting survival in stage melanoma based on tumor progression. J Natl Cancer Inst 1989; 81: 1893-1904.
2. Szymik B, Woosley JT. Further validation of the prognostic model for stage 1 malignant melanoma based on tumor progression. J Cut Pathol 1993; 20: 50-53.
3. Rowley MJ, Cockerell CJ. Reliability of prognostic models in malignant melanoma. Am J Dermatopathol 1991; 13: 431-437.
4. Cox N, Jones SK, MacKie RM. Malignant melanoma of the head and neck in Scotland: an eight-year analysis of trends in prevalence, distribution and prognosis. Quart J Med 1987; 244: 661-670.
5. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Ass 1958; 53: 457-481.
6. Soong S-J, Shaw HM, Balch JM, et al. Predicting survival and recurrence in localized melanoma: a multivariate approach. World J Surg 1992; 16: 191-195.
7. Tilmann DM, Aitchison TC, Watt DC, et al. Stage II melanoma in the West of Scotland 1976-1985: prognostic factors for survival. Eur J Cancer 1991; 27: 870-876.
8. Keefe M, Mackie RM. The relationship between risk of death from cutaneous melanoma and thickness of primary tumour: no evidence for steps in risk. Br J Cancer 1991; 64: 598-602.
9. Mackie RM, Aitchison RC, Sirel JM, et al. Clinicopathological predictors of prognosis in subsets of melanoma patients. Br J Cancer 1995; 71: 173-176.
10. Criqui MH, Langer RD, Froneck A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Eng J Med 1992; 326: 381-386.
11. Takemoto S, Terasaki PI, Cecka JM, et al. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. N Engl J Med 1992; 327: 834-839
12. Seeff LB, Buskell-Bales Z, Wright EC, et al. Long-term mortality after transfusion-associated non-A non-B hepatitis. N Engl J Med 1992; 327: 1906-1911.
13. The Cardiac Arrhytmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent morcizine on survival after myocardial infarction. N Engl J Med 1992; 327: 227-233.
14. Breslow NE, Day NE. Statistical Methods in Cancer Research, Vol 2. the analysis of Cohort Studies. WHO International Agency for Research in Cancer (Scientific Publication No. 32) Lyon: IARC.
15. Everitt BS. Statistical Methods for Medical Investigations. Oxford: Oxford University Press, 1989: 83-98.
16. The International Non-Hodkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodkins's lymphoma. N Engl J Med 1993; 329: 987-994.
17. Morigughi S, Hayashi Y, Nose Y, et al. A comparison of the logistic regression and the Cox proportional hazard models in retrospective studies on the prognosis of patients with gastric cancer. J Surg Oncol 1993; 52: 97-13.